Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
Autor: | Amarenco P, Goldstein LB, Szarek M, Sillesen H, Rudolph AE, Callahan A III, Hennerici M, Simunovic L, Zivin JA, Welch MA, SPARCL (Stroke Prevention by Aggressive Reduction in Cholesterol Levels) Investigators, Amarenco, Pierre, Goldstein, Larry B, Szarek, Michael, Sillesen, Henrik, Rudolph, Amy E, Callahan, Alfred 3rd, Hennerici, Michael, Simunovic, Lisa, Zivin, Justin A |
---|---|
Zdroj: | Stroke (00392499); Dec2007, Vol. 38 Issue 12, p3198-3204, 7p |
Databáze: | Supplemental Index |
Externí odkaz: |